Skip to main content
. 2017 Apr 4;8:132. doi: 10.3389/fphar.2017.00132

Table 2.

The combined anticancer effects of curcumin and cisplatin on % tumor inhibition in breast cancer rats.

0th Day 3rd Day 6th Day 9th Day
BCC 100 178 (+78) 245 (+145) 292 (+192)
CUR 100 93 (−7) 85 (−15) 80 (−20)
CIS 100 88 (−12) 82 (−18) 76 (−24)
CUR + CIS 100 75 (−25) 57 (−43) 34 (−66)

Where BCC is breast cancer control, CUR is curcumin, CIS is cisplatin, and CUR + CIS is pre-treatment of curcumin (120 mg/kg) for 5 days, followed by single dose of cisplatin (7.5 mg/kg) on the 5th day.

HHS Vulnerability Disclosure